Sales and Marketing

Showing 15 posts of 11524 posts found.

FDA rejects long-acting version of Zyprexa

February 29, 2008 Sales and Marketing

Lilly has suffered a setback after the US medicines regulator rejected a new version of its top-selling product Zyprexa. The …

Working with NICE: the ingredients for success

February 29, 2008 Research and Development, Sales and Marketing NICE, healthcare, industry relations, pharma

NICE fascinates everyone in the industry, and NICE knows only too well that every move it makes is studied by …

Avastin receives surprise FDA approval

February 29, 2008 Sales and Marketing

The FDA gone against the advice of its own advisory panel to approve Genentech's Avastin as a first-line treatment for …

AstraZeneca fined $200m over Medicaid pricing

February 29, 2008 Sales and Marketing

A US court has ruled AstraZeneca must pay more than $200 million for inflating the prices of drugs prescribed under …

Latest news from Datamonitor

February 28, 2008 Sales and Marketing

Algeta to initiate US clinical trials for prostate cancer drug Cancer therapeutics company Algeta has said that it will commence …

Generics and Avandia decline will hold GSK back

February 8, 2008 Sales and Marketing

GlaxoSmithKline's chief executive-in-waiting Andrew Witty faces a difficult first year at the helm of the company after sales growth was …

Vectibix launched for bowel cancer in UK

February 8, 2008 Sales and Marketing colorectal cancer

Vectibix, a new treatment for advanced colorectal cancer, has been launched in the UK. The treatment from Amgen was first …

Latest news from Datamonitor

February 6, 2008 Sales and Marketing Coronado Biosciences, rnai

 Coronado Biosciences’ cancer treatment effective in animal modelsCoronado Biosciences has reported that the Bcl-2 inhibitor, apogossypol, effectively killed a variety …

Takeda snaps up Amgen products

February 6, 2008 Sales and Marketing

Takeda has bought marketing rights to 13 of Amgen's early stage products, boosting its flagging pipeline and letting Amgen recoup …

Torisel poised to gain lymphoma licence

February 1, 2008 Sales and Marketing

Wyeth's new cancer drug Torisel is set to gain approval for use in patients with a rare and difficult to …

Tamiflu resistance hits Roche

February 1, 2008 Sales and Marketing

Sales of the blockbuster flu treatment Tamiflu could receive a setback from new data showing significant resistance to the drug. …

AstraZeneca sales strong despite Nexium’s decline

February 1, 2008 Sales and Marketing

AstraZeneca achieved sales growth of 12% in 2007, despite a worrying decline in sales from its biggest seller, anti-ulcer drug …
The Gateway to Local Adoption Series

Latest content